Koyfin Home > Directory > Health Care > Amphastar Pharma > Enterprise Value

Amphastar Pharma Enterprise Value Chart (AMPH)

Amphastar Pharma annual/quarterly Enterprise Value from 2014 to 2018.
  • Amphastar Pharma Enterprise Value for the quarter ending March 03, 2018 was $848m a 8.52% increase of 72m year over year
  • Amphastar Pharma Annual Enterprise Value for 2017 was $864m a 4.70% increase of 41m from 2016
  • Amphastar Pharma Annual Enterprise Value for 2016 was $823m a 25.15% increase of 207m from 2015
  • Amphastar Pharma Annual Enterprise Value for 2015 was $616m a 19.35% increase of 119m from 2014
Other Valuation Metrics:
  • Amphastar Pharma Market Cap for the quarter ending March 03, 2018 was $869m a 6.01% increase of 52m year over year
  • Amphastar Pharma Price / Book for the quarter ending March 03, 2018 was 2.59 a 2.71% increase of 0.07 year over year
View Chart On Koyfin

Quarterly AMPH Enterprise Value Data

03/2018$848m
12/2017$864m
09/2017$789m
06/2017$776m
03/2017$631m
12/2016$823m
09/2016$832m
06/2016$700m
03/2016$514m
12/2015$616m

Annual AMPH Enterprise Value Data

2017$864m
2016$823m
2015$616m
2014$497m